HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Step transplant shows promise against tough blood cancers
Disease control CompletedThis study tested a two-step donor stem cell transplant in 51 people with high-risk blood cancers. The approach uses total-body radiation and chemo before the transplant to prepare the body, then donor stem cells are given to rebuild healthy blood cells and attack remaining cance…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 04:25 UTC
-
Can a single drug protect kidneys during cancer treatment?
Disease control CompletedThis study tested the drug pegloticase in 10 cancer patients with high uric acid levels caused by tumor lysis syndrome, a complication where dying cancer cells release substances into the blood. The goal was to see if pegloticase could quickly lower uric acid and protect kidney f…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE4 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:15 UTC
-
Personalized plans may boost transplant survival in seniors
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 patients over 60 receiving a stem cell transplant for blood cancers or bone marrow failure. The plan included tailored changes to diet, sleep, activity, and medications. The goal was to see if these changes …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:13 UTC
-
New antibiotic combo shows promise for fighting infections in cancer patients
Disease control CompletedThis study tested a new antibiotic combination (imipenem-relebactam) against standard antibiotics for treating fever caused by low white blood cells in 100 adults with cancer. The goal was to see if the new treatment works better at controlling infections and helps doctors use an…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New drug combo may reduce deadly transplant complication in blood cancer patients
Disease control CompletedThis study looked at 174 adults with blood cancers who received a stem cell transplant from an unrelated donor. Researchers compared different combinations of immune-suppressing drugs to find the best way to prevent graft-versus-host disease (GVHD), a serious complication where d…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Digital symptom tracking may ease cancer patients' daily struggles
Symptom relief CompletedThis study looked at whether using electronic health records to track and manage common cancer symptoms—such as pain, fatigue, sleep problems, anxiety, and depression—can improve quality of life and reduce urgent care visits. Over 50,000 cancer patients took part. The goal was to…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 04:13 UTC
-
Rose geranium spray offers hope for Chemo-Related nose troubles
Symptom relief CompletedThis study tested whether a nasal spray made with rose geranium in sesame oil can improve nose symptoms like dryness, discomfort, bleeding, or scabbing in cancer patients receiving chemotherapy. About 106 adults with cancer and nose symptoms joined this phase III trial. Half used…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Kindness and gratitude: a new approach to easing cancer distress?
Symptom relief CompletedThis study tested whether doing simple positive activities—like helping with household tasks or writing a gratitude letter—could improve quality of life for cancer patients from collectivist cultures (e.g., Latino, Asian American, African American). 75 patients and their caregive…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Can a simple test predict chemotherapy falls?
Knowledge-focused CompletedThis study followed 200 adults aged 40-85 with cancer who were about to start chemotherapy. Researchers measured symptoms like numbness, disability, and daily activity to find simple tests that could predict when patients are at higher risk for falls and loss of function. The goa…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
Cancer sepsis study: do stronger antibiotics speed recovery?
Knowledge-focused CompletedThis study looked at whether adding a type of antibiotic called aminoglycosides helps cancer patients with sepsis (a severe infection) recover from dangerously low blood pressure. Researchers studied 232 adult cancer patients with sepsis. They compared those who got standard anti…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:23 UTC
-
Wearable tech could transform cancer monitoring
Knowledge-focused CompletedThis study tested whether a wearable device and smartphone app can better track vital signs and symptoms in cancer patients than standard in-clinic checks. About 100 adults with various cancers participated. The goal was to see if remote monitoring could detect complications like…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 04:19 UTC
-
Scientists watch for clues to predict transplant complication
Knowledge-focused CompletedThis study followed 267 adults before and after stem cell transplants to understand why some develop chronic graft-versus-host disease (GVHD), a common complication. Researchers collected blood, saliva, and eye fluid samples and performed tests to spot early signs. The goal is to…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC
-
New program helps doctors tackle cancer survivor needs
Knowledge-focused CompletedThis study tested a training program for community healthcare providers to improve their knowledge and skills in caring for cancer survivors. 28 providers from Ohio hospitals participated in virtual sessions. The goal was to see if the program increased their comfort and ability …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
New program aims to ease cancer survivors' distress and improve follow-up care
Knowledge-focused CompletedThis study tested a program designed to help adolescent and young adult cancer survivors (ages 15-39) find healthcare resources, learn self-care skills, and get support. The goal was to see if the program could reduce cancer-related distress and help survivors follow recommended …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
New study aims to predict chemo risks for seniors
Knowledge-focused CompletedThis study looked at 182 older adults with blood cancer or lung cancer to see if a special calculator could predict who would have severe side effects from chemotherapy. Researchers measured patients' overall wellness before and after treatment. The goal is to help doctors choose…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC